Clinical Trial Update: 2D vs 3D Planning for High-Dose Rate (HDR) Gynecological Brachytherapy [Phase 2]

View source ↗

Summary

Phase 2 trial comparing 2D versus 3D planning for high-dose-rate gynecological brachytherapy in cervix and endometrial cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervix Cancer
• Endometrial Cancer

Snippet

Sponsor: AC Camargo Cancer Center | Conditions: Cervix Cancer, Endometrial Cancer | Phase 2 | Status: COMPLETED